A 40-year study published in Pregnancy has revealed that elevated glucose levels in the third trimester of insulin-dependent ...

Women with cardiovascular disease (CVD) have a substantially higher adiposity-associated risk for breast cancer.

Ozempic is an FDA-approved medication for people who have type 2 diabetes. It’s often prescribed “off-label” for weight loss ...

Why is the teen prediabetes crisis a growing concern for public health? This isn’t a distant future—it’s happening now. One ...

Early-onset type 2 diabetes nearly doubled in Sweden between 2006 and 2021, with the sharpest increases among young adults, ...

While a healthy lifestyle naturally has important benefits, yet seeking weight loss alone might not give an adequate picture ...

New body composition tests are replacing BMI as a more accurate way to assess health and fitness. Measuring muscle mass and body fat provides key insights into strength and longevity that the scale ...

Rhythm Pharmaceuticals' potential first-in-class HO drug, strong pipeline, and limited competition offer blockbuster potential. Click to read why RYTM is a Buy.

As the popularity of medications for weight loss, such as Ozempic and Wegovy, surges across North America, new research ...

The European Association for the Study of Obesity framework may offer a more sensitive measure of obesity than traditional body mass index.

Stratifying body mass index categories by waist circumference thresholds improves mortality risk prediction in postmenopausal women.

Historically, managing type 2 diabetes in advanced chronic kidney disease (CKD) has been challenging due to a lack of therapies and increased risks for adverse events.